AWARD AMOUNT $100,000 per project per year for up to two years POSTED DATE Monday, June 21, 2021 DEADLINE FOR APPLICATION Friday, September 17, 2021 ANTICIPATED AWARD DATE Monday, November 1, 2021
The Harvard Stem Cell Institute (HSCI) invites applications for seed grant funding for its Fall 2021 cycle.
The purpose of this program is to provide funding for innovative projects in the field of stem cell and regenerative biology that are a collaboration between two labs. HSCI strongly encourages proposals with a translational focus, or which are otherwise poised to accelerate the development of new stem cell-based therapies or cures. However, proposals at all stages of development are welcome. The HSCI intends to award up to five grants in response to this call for proposals, contingent upon the number and quality of the proposals received, as well as the availability of HSCI funds.... Read more about Call for Proposals: 2021 Fall HSCI Collaborative Seed Grants
The JDRF Center of Excellence in New England will accelerate beta cell replacement therapy
Harvard Stem Cell Institute (HSCI) co-director Douglas Melton, Ph.D., will lead a new multi-institutional center funded by JDRF to advance type 1 diabetes research. The JDRF Center of Excellence in New England will focus on the transplantation of beta cells, the insulin-producing cells of the pancreas that are attacked by the immune system during type 1 diabetes.
The center is also led by JDRF scientific staff leader Esther Latres, Ph.D. Other collaborators include...
Assistant Professor, Boston Children's Hospital and Dana-Farber Cancer Institute
We are interested in unlocking new paradigms of normal blood development with the long-term aim of building better models of childhood blood diseases....
HSCI researchers create ON-OFF switches to better control CAR T cell activity
HSCI scientists have created molecular ON-OFF switches to regulate the activity of CAR T cells, a potent form of cell-based immunotherapy that has shown dramatic success in treating some advanced cancers, but...
The Harvard Department of Stem Cell and Regenerative Biology (HSCRB) invites applications for Pilot Grant funding for 2021 under the NIH-funded P01 grant “Dissecting the establishment and regulation of human pluripotency” (PI Alexander Meissner).
The purpose of this funding program is to provide resources for proof-of-concept studies. These pilot grants are intended to increase our understanding of the basic biology of human pluripotent cells and their utility for translational applications.... Read more about Call for Proposals: P01 Pilot Grants 2021
Assistant Professor, Brigham and Women's Hospital Harvard Medical School
The van Galen laboratory investigates normal and malignant hematopoiesis, with a focus on acute myeloid leukemia (AML). We use innovative experimental and...
